Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | NCF1 | P14598 | 8/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5405524 | 0.78 | CYP1A2 (0.46) | CYP1A2NCF1 | |
| SCHEMBL5404930 | 0.75 | CYP1A2 (0.43) | CYP1A2NCF1ADRB2ADRB1SMN1; SMN2 | |
| SCHEMBL3970334 | 0.73 | CYP1A2 (0.44) | CYP1A2NCF1ADRB2ADRB1SMN1; SMN2 | |
| SCHEMBL3970337 | 0.73 | NCF1 (0.53) | CYP1A2NCF1SMN1; SMN2HTTKDM4E | |
| SCHEMBL4048580 | 0.73 | CYP1A2 (0.41) | CYP1A2NCF1ADRB2ADRB1SMN1; SMN2 | |
| SCHEMBL1201646 | 0.71 | RECQL (0.44) | SMN1; SMN2LMNANPSR1 | |
| SCHEMBL5898542 | 0.71 | CYP1A2 (0.60) | CYP1A2NCF1ADRB2ADRB1SMN1; SMN2 | |
| SCHEMBL3969618 | 0.70 | NCF1 (0.49) | CYP1A2NCF1SMN1; SMN2HTTKDM4E | |
| SCHEMBL3969617 | 0.70 | CYP1A2 (0.41) | CYP1A2NCF1SMN1; SMN2HTTKDM4E | |
| SCHEMBL1366357 | 0.69 | CYP1A2 (0.62) | CYP1A2NCF1SMN1; SMN2HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7294624-B2 | Osteoporosis; antiarthritic agents | BRISTOL MYERS SQUIBB COMPANY (US) | 2007-11-13 | — | — | US | disclosed |